Abstract
Molecular methods have proven extremely useful for the detection of occult tumor cells and can yield valuable clinical information as well as a better understanding of the mechanisms of metastasis and relapse of cancer (1). In the case of many hematopoietic malignancies, the presence of a unique molecular marker such as a chromosomal translocation has made this task relatively straightforward. Carcinomas generally lack such markers, however. Certain oncogene mutations have been targeted, but the lack of consistent and specific markers has remained problematic.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Glaves, D. (1986) Detection of circulating metastatic cells, in Cancer Metastasis: Experimental and Clinical Strategies (Welch, D. R., Bhuyan, B. K., and Liotta, L. A., eds.), Alan R. Liss, New York, pp. 151–165.
Moreno, J. G., Croce, C. M., Fisher, zR., et al. (1992) Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res. 52, 6110–6112.
Ghossein, R. A. and Rosai, J. (1996) Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 78, 10–16.
Raj, G. V., Moreno, J. G., and Gomella, L. G. (1998) Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 82, 1419–1442.
Katz, A. E., Olsson, C. A., Raffo, A. J., et al. (1994) Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 43, 765–775.
Oefelein, M. G., Kaul, K., Herz, B., Blum, M. D., Holland, J. M., Keeler, T. C., Cook, W. A., and Ignatoff, J. M. (1996) Molecular Detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J. Urol. 155, 238–242.
Oefelein, M. G., Ignatoff, J. M., Clemens, Q., Watkin, W., and Kaul, K. L. (1999) Clinical and molecular followup after radical retropubic prostatectomy. J. Urol. 162, 307–310.
Ignatoff, J. M., Oefelein, M. G., Watkin, W., et al. (1997) Prostate specific antigen-reverse transcriptase-polymerase chain reaction assay in preoperative staging of prostate cancer. J. Urol. 158, 1870–1875.
Israeli, R. S., Miller, W. H., Su, S. L., et al. (1994) Sensitive nested reverse transcriptase polymerase chain reaction detection of circulating prostate tumor cells: comparison of prostate specific membrane antigen and prostate specific antigen based assays. Cancer Res. 54, 6306–6310.
Seiden, M. V., Kantoff, P. W., Krithivas, K., et al. (1994) Detection of circulating tumor cells in men with localized prostate cancer. J. Clin. Oncol. 12, 2634–2639.
Jaakkola, S., Vornanen, T., Leinonen, J., et al. (1995) Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate specific antigen. Clin. Chem. 41, 182–186.
Loric, S., Dumas, F., Eschwege, P., et al. (1995) Enhanced detection of hematog-enous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Clin. Chem. 41, 1698–1704.
Sokoloff, M. H., Tso, C. L., Kaboo, R., et al. (1996) Quantitative polymerase chain reaction does not improve preoperative cancer staging: a clinico-pathological molecular analysis of 121 patients. J. Urol. 156, 1560–1566.
Ghossein, R. A., Rosai, J., Scher, H. I., et al. (1997) Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma. Urology 50, 100–105.
Kawakami, M., Okaneya, T., Furihata, K., et al. (1997) Detection of prostate cancer cells circulating in peripheral blood by reverse transcription-PCR for hKLK2. Cancer Res. 57, 4167–4170.
Corey, E., Arfman, E. W., Oswin, M. M., et al. (1997) Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages. Urology 50, 184–188.
Corey, E., Arfman, E. W., Liu, A. Y., et al. (1997) Improved protocol for reverse transcriptase polymerase chain reaction protocol with exogenous internal competitive control for prostate specific antigen mRNA in blood and bone marrow. Clin. Chem. 43, 443–452.
Gomella, L. G., Raj, G. V., and Moreno, J. G. (1997) Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. J. Urol. 158, 326–337.
Noguchi, M., Miyajima, J., Itoh, K., et al. (1997) Detection of circulating tumor cells in patients with prostate cancer using prostate specific membrane-derived primers in the polymerase chain reaction. Int. J. Urol. 4, 374–379.
Wood, D. P. and Banerjee, M. (1997) Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival. J. Clin. Oncol. 15, 3451.
Thiounn, N., Saporta, F., Flam, T. A., et al. (1997) Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases. Urology 50, 245–250.
Ellis, W. J., Vessella, R. L., Corey, E., et al. (1998) The value of a reverse-transcriptase polymerase chain reaction assay in preoperative staging and follow-up of patients with prostate cancer. J. Urol. 159, 1134–1138.
Vessela, R. L., Lange, P. H., Blumenstein, B. A., et al. (1998) Multicenter RT-PCR PSA clinical trial for preoperative staging of prostate cancer. J. Urol. 159, 292A.
Van Nguyen, C., Song, W., Scardino, P. T., et al. (1998) RT-PCR for PSA and hK2: implications for staging and patient management in men undergoing radical prostatectomy. J. Urol. 159, 292A.
Nejat, R. J., Katz, A. E., Benson, M. C., et al. (1998) Enhanced RT-PCR for PSA combined with serum PSA predicts pathologic stage and outcome in 300 radical prostatectomy patients. J. Urol. 159, 291 A.
Grasso, Y. Z., Gupta, M. K., Levin, H. S., et al. (1998) Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage. Cancer Res. 58, 1456–1459.
Krafft, A. E., Duncan, B. W., Bijwaard, K. E., Taubenberger, J. K., and Lichy, J. H. (1997) Optimization of the isolation and amplification of RNA from formalin-fixed, paraffin-embedded tissue: the Armed Forces Institute of Pathology experience and literature review. Mol. Diagn. 2, 217.
Kaul, K. L., Hanna, W. L., Luke, S., Oda, J., and King, S. T. (1997) Molecular assays for detecting micrometastases in patient blood. Clin. Chem. 43, S92.
Lintula, S. and Stenman, U. (1997) Expression of prostate-specific membrane antigen in peripheral blood leukocytes. J. Urol. 157, 1969.
Gala, J.-L., Heusterspreute, M., Loric, S., Hanon, F., Tombal, B., Van Cangh, P., De Nayer, P., and Phillipe, M. (1998) Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of prostate cells and standardization. Clin. Chem. 44, 472–481.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Kaul, K.L. (2001). Molecular Detection of Circulating Prostate Cancer Cells. In: Killeen, A.A. (eds) Molecular Pathology Protocols. Methods in Molecular Medicine™, vol 49. Humana Press. https://doi.org/10.1385/1-59259-081-0:177
Download citation
DOI: https://doi.org/10.1385/1-59259-081-0:177
Publisher Name: Humana Press
Print ISBN: 978-0-89603-681-9
Online ISBN: 978-1-59259-081-0
eBook Packages: Springer Protocols